-
Something wrong with this record ?
Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study
S. Enriquez-Geppert, J. Krc, FJ. O'Higgins, M. Lietz
Language English Country England, Great Britain
Document type Journal Article, Randomized Controlled Trial
NLK
Free Medical Journals
from 2001 to 1 year ago
PubMed Central
from 1997 to 1 year ago
Europe PubMed Central
from 1997 to 1 year ago
Open Access Digital Library
from 1887-01-01
Open Access Digital Library
from 1997-01-01
- MeSH
- Adult MeSH
- Executive Function * drug effects MeSH
- Humans MeSH
- Young Adult MeSH
- Neurofeedback * methods MeSH
- Psilocybin * pharmacology MeSH
- Feasibility Studies * MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Randomized Controlled Trial MeSH
Executive function deficits, common in psychiatric disorders, hinder daily activities and may be linked to diminished neural plasticity, affecting treatment and training responsiveness. In this pioneering study, we evaluated the feasibility and preliminary efficacy of psilocybin-assisted frontal-midline theta neurofeedback (NF), a neuromodulation technique leveraging neuroplasticity, to improve executive functions (EFs). Thirty-seven eligible participants were randomized into an experimental group (n = 18) and a passive control group (n = 19). The experimental group underwent three microdose sessions and then three psilocybin-assisted NF sessions, without requiring psychological support, demonstrating the approach's feasibility. NF learning showed a statistical trend for increases in frontal-midline theta from session to session with a large effect size and non-significant but medium effect size dynamical changes within sessions. Placebo effects were consistent across groups, with no tasks-based EF improvements, but significant self-reported gains in daily EFs-working memory, shifting, monitoring and inhibition-showing medium and high effect sizes. The experimental group's significant gains in their key training goals underscored the approach's external relevance. A thorough study with regular sessions and an active control group is crucial to evaluate EFs improvement and their specificity in future. Psilocybin-enhanced NF could offer significant, lasting benefits across diagnoses, improving daily functioning. This article is part of the theme issue 'Neurofeedback: new territories and neurocognitive mechanisms of endogenous neuromodulation'.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003116
- 003
- CZ-PrNML
- 005
- 20250206104042.0
- 007
- ta
- 008
- 250121s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1098/rstb.2023.0095 $2 doi
- 035 __
- $a (PubMed)39428872
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Enriquez-Geppert, S $u Department of Clinical and Developmental Neuropsychology, University of Groningen , Groningen, Netherlands $u Department of Biomedical Sciences of Cells & Systems, University Medical Center Groningen , Groningen, Netherlands $1 https://orcid.org/0000000173050111
- 245 10
- $a Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study / $c S. Enriquez-Geppert, J. Krc, FJ. O'Higgins, M. Lietz
- 520 9_
- $a Executive function deficits, common in psychiatric disorders, hinder daily activities and may be linked to diminished neural plasticity, affecting treatment and training responsiveness. In this pioneering study, we evaluated the feasibility and preliminary efficacy of psilocybin-assisted frontal-midline theta neurofeedback (NF), a neuromodulation technique leveraging neuroplasticity, to improve executive functions (EFs). Thirty-seven eligible participants were randomized into an experimental group (n = 18) and a passive control group (n = 19). The experimental group underwent three microdose sessions and then three psilocybin-assisted NF sessions, without requiring psychological support, demonstrating the approach's feasibility. NF learning showed a statistical trend for increases in frontal-midline theta from session to session with a large effect size and non-significant but medium effect size dynamical changes within sessions. Placebo effects were consistent across groups, with no tasks-based EF improvements, but significant self-reported gains in daily EFs-working memory, shifting, monitoring and inhibition-showing medium and high effect sizes. The experimental group's significant gains in their key training goals underscored the approach's external relevance. A thorough study with regular sessions and an active control group is crucial to evaluate EFs improvement and their specificity in future. Psilocybin-enhanced NF could offer significant, lasting benefits across diagnoses, improving daily functioning. This article is part of the theme issue 'Neurofeedback: new territories and neurocognitive mechanisms of endogenous neuromodulation'.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a neurofeedback $x metody $7 D058765
- 650 12
- $a psilocybin $x farmakologie $7 D011562
- 650 12
- $a exekutivní funkce $x účinky léků $7 D056344
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a studie proveditelnosti $7 D005240
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Krc, J $u Department of Clinical and Developmental Neuropsychology, University of Groningen , Groningen, Netherlands $u Department of Psychiatry, Faculty of Medicine, Masaryk University and University Hospital Brno , Brno, Czech Republic
- 700 1_
- $a O'Higgins, F J $u Trinity College Institute of Neuroscience, School of Medicine, Trinity College Dublin, The University of Dublin , Dublin, Ireland $u Academic Unit of Neurology, Trinity Biomedical Sciences Institute, School of Medicine, Trinity College Dublin, The University of Dublin , Dublin, Ireland
- 700 1_
- $a Lietz, M $u Department of Clinical and Developmental Neuropsychology, University of Groningen , Groningen, Netherlands $u Department of Medicine, Faculty of Science and Medicine, University of Fribourg , Fribourg, Switzerland
- 773 0_
- $w MED00192920 $t Philosophical transactions - Royal Society of London. Biological sciences $x 1471-2970 $g Roč. 379, č. 1915 (2024), s. 20230095
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39428872 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104037 $b ABA008
- 999 __
- $a ok $b bmc $g 2263085 $s 1239123
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 379 $c 1915 $d 20230095 $e 20241021 $i 1471-2970 $m Philosophical transactions - Royal Society of London. Biological sciences $n Philos Trans R Soc Lond B Biol Sci $x MED00192920
- LZP __
- $a Pubmed-20250121